These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 8117425
1. Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein. Wallace W, Haroutunian V. Behav Brain Res; 1993 Nov 30; 57(2):199-206. PubMed ID: 8117425 [Abstract] [Full Text] [Related]
2. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model. Vanden Dries V, Stygelbout V, Pierrot N, Yilmaz Z, Suain V, De Decker R, Buée L, Octave JN, Brion JP, Leroy K. Neurobiol Aging; 2017 Jul 30; 55():202-212. PubMed ID: 28464981 [Abstract] [Full Text] [Related]
3. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E, Schliebs R. Curr Pharm Des; 2013 Jul 30; 19(38):6749-65. PubMed ID: 23530514 [Abstract] [Full Text] [Related]
4. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Wallace W, Ahlers ST, Gotlib J, Bragin V, Sugar J, Gluck R, Shea PA, Davis KL, Haroutunian V. Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8712-6. PubMed ID: 8378353 [Abstract] [Full Text] [Related]
5. Cholinergic immunolesions by 192IgG-saporin--useful tool to simulate pathogenic aspects of Alzheimer's disease. Rossner S. Int J Dev Neurosci; 1997 Nov 15; 15(7):835-50. PubMed ID: 9568532 [Abstract] [Full Text] [Related]
6. Cholinergic neuropathology in a mouse model of Alzheimer's disease. German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL. J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807 [Abstract] [Full Text] [Related]
7. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex. Yilmazer-Hanke DM. Acta Anat (Basel); 1998 Aug 04; 162(1):46-55. PubMed ID: 9789108 [Abstract] [Full Text] [Related]
9. The cholinergic system in aging and neuronal degeneration. Schliebs R, Arendt T. Behav Brain Res; 2011 Aug 10; 221(2):555-63. PubMed ID: 21145918 [Abstract] [Full Text] [Related]
10. [Alzheimer disease: cellular and molecular aspects]. Octave JN. Bull Mem Acad R Med Belg; 2005 Aug 10; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [Abstract] [Full Text] [Related]
11. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation. Yilmazer-Hanke DM, Hanke J. Dement Geriatr Cogn Disord; 1999 Aug 10; 10(2):70-6. PubMed ID: 10026378 [Abstract] [Full Text] [Related]
12. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Schliebs R. Neurochem Res; 2005 Aug 10; 30(6-7):895-908. PubMed ID: 16187224 [Abstract] [Full Text] [Related]
13. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. Kar S, Slowikowski SP, Westaway D, Mount HT. J Psychiatry Neurosci; 2004 Nov 10; 29(6):427-41. PubMed ID: 15644984 [Abstract] [Full Text] [Related]
19. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue. Martins RN, Taddei K, Kendall C, Evin G, Bates KA, Harvey AR. Neuroscience; 2001 Nov 10; 106(3):557-69. PubMed ID: 11591456 [Abstract] [Full Text] [Related]
20. [Pathogenetic factors of Alzheimer disease]. Bauer J, Hüll M, Berger M. Z Gerontol Geriatr; 1995 Nov 10; 28(3):155. PubMed ID: 7664189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]